Brief: Lipocine Inc Spyros Papapetropoulos Resigns As Board Member Effective April 16, 2026
21/04/2026 23:23
April 21 (Reuters) - Lipocine Inc LPCN.O: LIPOCINE INC - SPYROS PAPAPETROPOULOS RESIGNS AS BOARD MEMBER EFFECTIVE APRIL 16, 2026 - SEC FILING LIPOCINE INC - APPOINTS R. DANA ONO AS CHAIRMAN OF BOARD AND LEAD INDEPENDENT DIRECTOR ON APRIL 20, 2026 - SEC FILING Source text: [ID:n0001493152-26-018299] Further company coverage: LPCN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy